BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 5893656)

  • 1. [Pharmacological studies on decanohydroxamic acid. 3. General pharmacological action. (2)].
    Kitagawa H; Yoshida S; Abe M; Ohno F
    Yakugaku Zasshi; 1965 Oct; 85(10):912-6. PubMed ID: 5893656
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pharmacological studies on decanohydroxamic acid. V. Percutaneous absorption, distribution on rats and percutaneous subacute toxicity on rabbits].
    Kitagawa H; Yoshida S; Abe M; Fukuda Y
    Yakugaku Zasshi; 1965 Nov; 85(11):1017-21. PubMed ID: 5893831
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationships between structure and four types of pharmacologic activity in arylacetydroxamic acids.
    Lambelin G; Buu-Hoï NP; Brouilhet H; Gautier M; Gillet C; Roba J; Thiriaux J
    Arzneimittelforschung; 1968 Nov; 18(11):1404-8. PubMed ID: 4885157
    [No Abstract]   [Full Text] [Related]  

  • 4. [To the mechanism of hypotensive effect of ethyl ether of nicotinic acid (Nicethane)].
    Sidoruk GIa
    Farmakol Toksikol; 1966; 29(2):135-6. PubMed ID: 6000335
    [No Abstract]   [Full Text] [Related]  

  • 5. The hypotensive effect of dauricine and its mechanism of action.
    Chen SH; Hu CJ
    Acta Acad Med Wuhan; 1983; 3(2):125-7. PubMed ID: 6866387
    [No Abstract]   [Full Text] [Related]  

  • 6. [Suppression or reversion of the hypertensive action of adrenaline and noradrenaline in the rabbit by isoxsuprine; its action opposeded by some "dereversing" substances].
    Hazard R; Mouillé P
    C R Seances Soc Biol Fil; 1967; 161(10):1908-11. PubMed ID: 4234168
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pharmacological study of p-butoxyphenylacethydroxamic acid (CP 1044 J3). II. Toxicological research].
    Lambelin G; Buu-Hoi NP; Mees G; Thiriaux J; Huriaux M
    Med Pharmacol Exp Int J Exp Med; 1966; 15(6):545-54. PubMed ID: 6013064
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological studies on decanohydroxamic acid. IV. Subacute oral toxicity on rats].
    Kitagawa H; Yoshida S; Abe M; Fukuda Y
    Yakugaku Zasshi; 1965 Nov; 85(11):1012-6. PubMed ID: 5893830
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemical and pharmacological properties of urotensin I, a long acting mammalian hypotensive peptide.
    Lederis K
    Acta Physiol Lat Am; 1974; 24(5):481-3. PubMed ID: 4467676
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pharmacological studies on decanohydroxamic acid. II. General pharmacological action. (1)].
    Kitagawa H; Yoshida S; Abe M; Oyama T
    Yakugaku Zasshi; 1965 Oct; 85(10):909-11. PubMed ID: 4379485
    [No Abstract]   [Full Text] [Related]  

  • 11. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator and hypotensive effects of droperidol.
    Bobadilla RA; Valencia I; Ibarra M; Castillo EF; Castillo C; Hong E
    Proc West Pharmacol Soc; 1994; 37():9-10. PubMed ID: 7984684
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacological studies on decanohydroxamic acid. I. Antifungal action].
    Kitagawa H; Yoshida S; Abe M; Chen W; Arai T
    Yakugaku Zasshi; 1965 Sep; 85(9):860-2. PubMed ID: 5893181
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthesis and pharmacological activity of pyrazolopyrrolopyrimidine derivatives having vasorelaxing activity.
    Kumagai T; Matsunaga H; Kaneda S; Shimizu H; Ebisawa E; Kitamura M; Suzuki T; Yuasa M; Nagao Y
    Drug Des Discov; 1999 Aug; 16(2):171-5. PubMed ID: 10533813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride, a new, antihypertensive substance].
    Hoefke W; Kobinger W
    Arzneimittelforschung; 1966 Aug; 16(8):1038-50. PubMed ID: 6014885
    [No Abstract]   [Full Text] [Related]  

  • 16. The antihypertensive and vasodilator effects of aqueous extract from Berberis vulgaris fruit on hypertensive rats.
    Fatehi-Hassanabad Z; Jafarzadeh M; Tarhini A; Fatehi M
    Phytother Res; 2005 Mar; 19(3):222-5. PubMed ID: 15934023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antihypertensive drugs on ethanol induced gastric lesions: is there a correlation with mucosal blood flow?
    Rataboli PV; Diniz D'Souza RS; Dhume VG
    Indian J Physiol Pharmacol; 1993 Jan; 37(1):88-90. PubMed ID: 8449556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preliminary pharmacodynamic studies of ketolactone isolated from Feronia elephantum Corr.
    Tewari JP; Mishra SS
    J Exp Med Sci; 1965 Sep; 9(2):36-8. PubMed ID: 5886393
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white.
    Miguel M; Manso M; Aleixandre A; Alonso MJ; Salaices M; López-Fandiño R
    J Agric Food Chem; 2007 Dec; 55(26):10615-21. PubMed ID: 18047278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive and endothelium-dependent vasodilator effects of aqueous extract of Cistus ladaniferus.
    Belmokhtar M; Bouanani NE; Ziyyat A; Mekhfi H; Bnouham M; Aziz M; Matéo P; Fischmeister R; Legssyer A
    Biochem Biophys Res Commun; 2009 Nov; 389(1):145-9. PubMed ID: 19715668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.